| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Escherichia coli (nalidixic acid-resistant) |
1 |
2 |
0.5 － 4 |
Moxifloxacin (BAY 12-8039, Avelox)  |
244 |
| Escherichia coli (nalidixic acid-resistant) |
2 |
2 |
0.5 － >4 |
Grepafloxacin (Raxar) |
244 |
| Escherichia coli (nalidixic acid-resistant) |
>32 |
>32 |
>32 － ? |
Nalidixic acid (NegGam) |
244 |
| Escherichia coli (nalidixic acid-susceptible) |
≤0.015 |
≤0.015 |
≤0.015 － 0.03 |
AF 3013 |
244 |
| Escherichia coli (nalidixic acid-susceptible) |
≤0.015 |
≤0.015 |
≤0.015 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
244 |
| Escherichia coli (nalidixic acid-susceptible) |
0.03 |
0.06 |
≤0.015 － 0.06 |
Trovafloxacin (Trovan) |
244 |
| Escherichia coli (nalidixic acid-susceptible) |
0.03 |
0.06 |
0.03 － 0.12 |
Levofloxacin (Levaquin, Quixin) |
244 |
| Escherichia coli (nalidixic acid-susceptible) |
0.03 |
0.12 |
0.03 － 0.25 |
Grepafloxacin (Raxar) |
244 |
| Escherichia coli (nalidixic acid-susceptible) |
0.06 |
0.12 |
0.03 － 0.5 |
Moxifloxacin (BAY 12-8039, Avelox) |
244 |
| Escherichia coli (nalidixic acid-susceptible) |
4 |
4 |
2 － >4 |
Nalidixic acid (NegGam) |
244 |
| Escherichia coli (NBRC 3301 + K-12) |
- |
- |
>50 － ? |
Ornithodoros defensin A |
251 |
| Escherichia coli (NCIM 2931) |
- |
- |
0.001 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
765 |
| Escherichia coli (NCIM 2931) |
- |
- |
0.005 － ? |
Ampicillin (Omnipen) |
765 |
| Escherichia coli (NCIM 2931) |
- |
- |
10 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
922 |
| Escherichia coli (NCIM 2931) |
- |
- |
10 － ? |
Streptomycin |
922 |
| Escherichia coli (NCIM 2931) |
- |
- |
40 － ? |
Biosurfactant |
922 |
| Escherichia coli (NCIMB 10000) |
- |
- |
4.5 － ? |
Zinc pyrithione |
1411 |
| Escherichia coli (NCIMB 10000) |
- |
- |
16 － ? |
Cetrimide |
1411 |
| Escherichia coli (NCIMB 10000) |
- |
- |
20 － ? |
Benzisothiazolone |
1411 |
| Escherichia coli (NCIMB 10000) |
- |
- |
25 － ? |
Dichlorophen |
1411 |
| Escherichia coli (NCIMB 10000) |
- |
- |
30 － ? |
Fentichlor |
1411 |
| Escherichia coli (NCIMB 10000) |
- |
- |
120 － ? |
Sodium pyrithione |
1411 |
| Escherichia coli (NCTC 09001 + O157:H7 + Greece) |
- |
- |
5000 － ? |
Propolis (Ethanol extract) |
1149 |
| Escherichia coli (NCTC 10416) |
- |
- |
3.9 － ? |
Cirramycin-B |
816 |
| Escherichia coli (NCTC 10416) |
- |
- |
>100 － ? |
WA52-A |
1170 |
| Escherichia coli (NCTC 10418) |
- |
- |
0.008 － ? |
Ceftizoxime (Cefizox) |
401 |
| Escherichia coli (NCTC 10418) |
- |
- |
0.015 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
401 |
| Escherichia coli (NCTC 10418) |
- |
- |
0.015 － ? |
Gatifloxacin (Tequin) |
401 |